Summary statement: the Sygen(GM-1 ganglioside) clinical trial in acute spinal cord injury.
Fehlings
M G
MG
Bracken
M B
MB
D000208:Acute Disease; D005677:G(M1) Ganglioside / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D006801:Humans; D015337:Multicenter Studies as Topic; D018696:Neuroprotective Agents / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D013119:Spinal Cord Injuries / Q000188:drug therapy* / Q000503:physiopathology; D016896:Treatment Outcome
D018696:Neuroprotective Agents; D005677:G(M1) Ganglioside; C051355:siagoside